Open Free Energy has achieved industry-validated precision in its analysis across 15 pharmaceutical companies through participation in the largest open benchmarking study of free energy methods. This milestone reinforces Open Free Energy’s role in providing accurate solutions for drug discovery and development processes.
Conducted by leading experts in the field, the benchmarking study evaluated various free energy calculation methods to assess their reliability and applicability in the pharmaceutical industry. The results demonstrated that Open Free Energy’s methods consistently delivered the highest accuracy among participants, positioning it as a key contributor in advancing pharmaceutical research.
This achievement highlights the growing importance of innovative computational techniques in drug discovery, offering pharmaceutical companies the opportunity to enhance their research capabilities and accelerate the development of new therapeutics. Open Free Energy continues to lead the way in providing cutting-edge solutions that meet the evolving needs of the global pharmaceutical sector.